Point72 Asia Singapore Pte. Ltd. Has $1.33 Million Position in Danaher Co. (NYSE:DHR)

Point72 Asia Singapore Pte. Ltd. cut its holdings in Danaher Co. (NYSE:DHR) by 78.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,786 shares of the conglomerate’s stock after selling 21,132 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Danaher were worth $1,328,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of DHR. Norges Bank bought a new stake in shares of Danaher during the fourth quarter worth $2,130,740,000. Raymond James Financial Inc. bought a new position in Danaher during the 4th quarter worth about $391,172,000. Capital World Investors raised its stake in shares of Danaher by 32.7% in the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares during the period. Point72 Asset Management L.P. lifted its holdings in shares of Danaher by 460.6% in the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate’s stock valued at $309,558,000 after purchasing an additional 1,107,998 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Danaher by 14.3% during the fourth quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate’s stock worth $1,821,477,000 after buying an additional 992,594 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on DHR shares. Barclays upped their price target on Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 22nd. Citigroup restated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Guggenheim reiterated a “buy” rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, April 23rd. Raymond James restated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $264.40.

Insider Buying and Selling at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $188.32 on Thursday. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a market capitalization of $134.77 billion, a price-to-earnings ratio of 35.67, a PEG ratio of 2.66 and a beta of 0.80. The company has a 50-day simple moving average of $197.35 and a 200 day simple moving average of $218.33. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. On average, sell-side analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.